Pure Bioscience PURE

Pure Bioscience is dedicated to developing and commercializing proprietary antimicrobial products that address health and environmental challenges related to pathogen and hygienic control. The company's technology platform is based on patented stabilized ionic silver, specifically Silver Dihydrogen Citrate (SDC), which serves as the foundation for its product portfolio. Pure Bioscience focuses on delivering safe, effective, and environmentally responsible antimicrobial solutions primarily for the food industry, while also serving healthcare, personal care, and facility care markets.

Pure Bioscience generates revenue through the manufacturing, distribution, and sale of its SDC-based products directly to end-use customers and via third-party distributors. The company sells ready-to-use disinfectants and sanitizers, concentrates for dilution, and SDC as a raw material ingredient for incorporation into other products, particularly in personal care formulations. Revenue is derived from product sales across multiple industries, with a strategic emphasis on expanding its distribution network to increase market reach and sales efficiency.

Pure Bioscience operates through the following segments: Food Safety, Personal Care Ingredients, and Industrial and Institutional Cleaning.

• Food Safety: This segment focuses on antimicrobial solutions for food processing, food service, hospitality, and transportation industries. Key products include PURE® Hard Surface, a food contact surface sanitizer and disinfectant, and PURE Control®, an FDA-approved direct food contact processing aid for poultry and produce. The segment also includes PURE® Multi-Purpose Hi-Foam Cleaner Concentrate and PURE® Multi-Purpose and Floor Cleaner, which complement the disinfecting products in sanitation protocols. These products are EPA-registered and designed to combat pathogens such as Salmonella, E. coli, Listeria, MRSA, and SARS-CoV-2 while maintaining low toxicity and non-corrosive properties.
• Personal Care Ingredients: This segment involves the supply of SDC-based formulations as raw material ingredients for manufacturers of personal care products. The primary offering is SILVÉRION®, a patented SDC-based antimicrobial formulation used as an active ingredient or preservative in products such as SILVÉRION 2400. SILVÉRION is marketed for its efficacy against bacteria, viruses, yeast, and molds, and is sold both domestically and internationally for use in cosmetics and personal care applications. The segment leverages the non-toxic, odorless, and colorless properties of SDC to meet demand for safer preservative alternatives in personal care formulations.
• Industrial and Institutional Cleaning: This segment provides SDC-based cleaning and disinfecting products for healthcare facilities, schools, offices, childcare centers, and commercial buildings. Products in this segment include PURE® Hard Surface, PURE® Multi-Purpose Cleaner, and PURE® Hi-Foam Cleaner, which are used to maintain hygienic environments without requiring personal protective equipment due to their low toxicity. The segment emphasizes ease of use, material compatibility, and effectiveness against drug-resistant organisms and viruses in high-traffic or sensitive environments.

Pure Bioscience holds a niche position in the antimicrobial industry as a developer of stabilized ionic silver technology, differentiating itself from traditional chemical disinfectants that often carry higher toxicity and environmental concerns. The company competes with established providers of quaternary ammonium compounds, chlorine-based agents, and peracetic acid, but distinguishes its SDC-based products through EPA Category IV toxicity rating, non-corrosive formulation, and resistance to microbial adaptation. Its intellectual property portfolio, including twelve U. S. patents and registered trademarks such as PURE®, SILVÉRION®, and PURE Control®, supports its competitive advantage in product innovation and market differentiation.

Pure Bioscience serves a diverse customer base including food processors, restaurant chains, hospitals, assisted living facilities, schools, commercial office buildings, transportation companies, and personal care product manufacturers. The company also works with third-party distributors who resell its products across these sectors. While specific customer names are not disclosed in the filing, the company notes that its top three customers accounted for $787,000 in net product sales for the fiscal year ended July 31, 2025, with one customer representing 18% of total revenue during that period.